小狗阅读会员会员
医学顶刊SCI精读工具

扫码登录小狗阅读

阅读SCI医学文献
Document
订阅泛读方向 订阅泛读期刊
  • 我的关注
  • 我的关注
  • {{item.title}}

    按需关注领域/方向,精准获取前沿热点

  • {{item.title}}

    {{item.follow}}人关注

  • {{item.subscribe_count}}人订阅

    IF:{{item.impact_factor}}

    {{item.title}}

[Analysis of sugammadex for antagonistic neuromuscular block in patients with radical resection of lung cancer under thoracoscope].

[Sugammadex用于胸腔镜下肺癌根治术患者拮抗性神经肌肉阻滞的分析]。

  • 影响因子:0
  • DOI:10.3760/cma.j.issn.0376-2491.2020.03.011
  • 作者列表:"Ba YF","Liu YN","He SH","Li HM","Wang HR","Zhu JP","Xing WQ","Li CS
  • 发表时间:2020-01-21
Abstract

:Objective: To investigate the efficacy and safety of sugammadex for antagonistic neuromuscular block in patients with radical resection of lung cancer under thoracoscope. Methods: One hundred patients undergoing radical resection of lung cancer under thoracoscope in Affiliated Cancer Hospital of Zhengzhou University from March to September in 2019, were randomly divided into control group (group C) and sugammadex group (group S). All patients were anaesthetized (induced and maintained) with intravenous target-controlled infusion of propofol and remifentanil, and intermittent intravenous injection of the neuromuscular block of rocuronium. During the operation, the bispectral index (BIS) was used to monitor the depth of anesthesia, and the neuromuscular block was assessed with TOF. Single-lung mechanical ventilation and double-lumen endotracheal intubation were carried out, and patient-controlled analgesia after operation were enforced. Patients in group C received neostigmine (2 mg) combined with atropine (0.5-1.0 mg) after thoracic closure, while patients in group S received sugammadex (2 mg/kg) at TOF count (≥2) after thoracic closure, and then double-lumen endotracheal tubes were extubated according to extubation indications. At these time points: T(0) (immediate before anesthesia induction), T(1) (immediate before tracheal intubation), T(2) (immediately after thoracic closure), T(3) (1 h after operation), T(4) (6 h after operation), T(5) (24 h after operation), T(6)(48 h after operation), the heart rate(HR) and mean arterial pressure (MAP) were recorded, QT interval (V3 ECG) were measured and calculated, indicators of liver function [alanine transaminase (ALT), aspartate transaminase(AST)], renal function [blood urea nitrogen (BUN), creatinine (Cre)] and clotting function [thrombin time (TT), prothrombin time (PT), activated partial thromboplastin time (APTT) and fibrinogen (FIB)] were detected. The duration of operation, postoperative conditions within 48 hours after operation(the time of tracheal tube extubation, respiratory suppression/dysfunction, allergy, nausea and vomiting, itching of skin, abnormal sensation), pathological types and the postoperative hospital stay were recorded. Results: There were no significant differences of the age, sex ratio, body mass index (BMI), American Society of Anesthesiologists (ASA) grading ratio, duration of operation, pathological types and the postoperative hospital stay, HR, MAP and QT interval between two groups (all P>0.05). There were no remarkable differences of the levels of serum histamine, ALT, AST, BUN, Cre, TT, PT, APTT and FIB before and after administration of neuromuscular blockade antagonists (neostigmine or Sugammadex) in the same group patients (all P>0.05), also no significant differences between group C and group S at the same time points (all P>0.05). Average time of tracheal tube extubation in group S [(3.7±1.3) min] was sharply shorter than that in group C [(14.5±4.4) min, t=2.266, P<0.05)]. There were no patients with allergy, skin itching, sensory abnormality in these two groups. There were no significant difference of the incidence of postoperative nausea and vomiting between these two groups. There were 5 patients with respiratory depression in group C and no respiratory depression patient in group S, the difference was statistically significant between these two groups (χ(2)=5.263, P<0.05). Conclusion: Sugammadex is effective for antagonizing the neuromuscular blockade of rocuronium in patients with radical resection of lung cancer under thoracoscope, and can shorten the time of tracheal tube extubation after surgery. :目的: 探讨舒更葡糖钠用于胸腔镜肺癌根治术患者拮抗肌松药作用的有效性和安全性。 方法: 本研究为前瞻性研究。选取2019年3至9月在郑州大学附属肿瘤医院拟行胸腔镜肺癌根治术患者100例,随机数字表法分为对照组(C组)、舒更葡糖钠组(S组)。两组患者均进行静脉靶控输注丙泊酚和瑞芬太尼、静脉推注罗库溴铵进行麻醉诱导和维持,脑电双频指数(BIS)监测麻醉深度,肌松监测仪(TOF)检测肌松,双腔导管气管内插管,单肺机械通气,术后患者自控镇痛(PCA)。C组患者在关闭胸腔后且有自主呼吸时静脉推注新斯的明(2 mg)联合阿托品(0.5~1.0 mg)逆转肌松药作用;S组在关闭胸腔后TOF计数≥2时(无论有无自主呼吸)静脉推注舒更葡糖钠(2 mg/kg);两组患者均参照拔管指征拔除气管导管。检测麻醉诱导前即刻(T(0))、气管插管前即刻(T(1))、关闭胸腔后即刻(T(2))、术后1 h(T(3))、术后6 h(T(4))、术后24 h(T(5))、术后48 h(T(6))患者平均动脉压,心率,V3导联心电图的QT间期,血清谷丙转氨酶(ALT),谷草转氨酶(AST),肾功能[血尿素氮(BUN)、血肌酐(Cre)]和凝血功能[血浆凝血酶时间(TT)、血浆凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)],并记录患者的手术时间、气管导管拔除时间、术后48 h内呼吸抑制、呼吸功能障碍、过敏、恶心呕吐、皮肤瘙痒、感觉异常的发生率,以及术后病理分型、术后住院天数等情况。 结果: 两组患者年龄、性别、体质指数(BMI)、美国麻醉医师协会(ASA)分级、手术时间、术后病理分型、术后住院天数差异均无统计学意义(均P>0.05);两组患者心率、血压和QT间期差异均无统计学意义(均P>0.05);两组患者在应用肌松拮抗剂前后血清组胺、肝功能指标(ALT和AST)、肾功能指标(BUN和Cre)差异均无统计学意义(均P>0.05),相同时间点两组间血清组胺、肝功能指标、肾功能指标差异均无统计学意义(均P>0.05);两组患者在应用肌松拮抗剂前后出/凝血功能指标(TT、PT、APTT和FIB)差异均无统计学意义(均P>0.05),相同时间点两组间出/凝血功能指标差异均无统计学意义(均P>0.05);S组患者术后气管导管拔管时间为(3.7±1.3)min,短于C组患者的(14.5±4.4)min,差异有统计学意义(t=2.266,P<0.05);两组术后48 h内均无呼吸功能障碍、过敏、皮肤瘙痒和感觉异常患者,术后恶心呕吐发生率两组差异无统计学意义(P>0.05);术后48 h内C组呼吸抑制患者5例,S组无呼吸抑制患者,差异有统计学意义(χ(2)=5.263,P<0.05)。 结论: 肺癌根治术患者术毕应用舒更葡糖钠拮抗罗库溴铵的肌松作用是有效的,可以缩短术后气管导管拔管时间。.

摘要

: 目的: 探讨的sugammadex的拮抗神经肌肉阻滞的临床肺癌根治术胸腔镜下.方法: 采用一百根治术患者肺癌胸腔镜下在附属肿瘤医院河南省郑州大学从三月到九月 2019 年年,按随机数字表法分为对照组 (C组) 和sugammadex组 (S组).所有患者均行腹腔注射 (诱导和维持) 与静脉靶控输注丙泊酚与瑞芬太尼,间断静脉注射神经肌肉阻滞罗库溴铵.在手术过程中,脑电双频指数 (BIS) 监测麻醉深度,和神经肌肉阻滞评分评价法洛四联症根治术的.单肺通气策略和双腔气管插管进行,与静脉自控镇痛术后强迫.C组患者新斯的明 (2 mg) 联合阿托品 (0.5-1.0 mg) 后关胸,对照组患者采用S组sugammadex (2 mg/kg) 在TOF计数 (≥ 2) 的胸部,然后双腔气管管拔管根据拔管指征.这些时间点: T(0) (即时麻醉诱导前),T(1) (a) 立即气管插管前),T(2) (后立即关胸),T(3) (1 h),T(4) (6 h),T(5) (24 h),T(6)(48 h),心率 (HR) 、平均动脉压 (MAP),QT间期 (V3 ECG) 的含量并计算,指标肝功能 [丙氨酸氨基转移酶 (ALT),天冬氨酸氨基转移酶 (AST),肾功能血液尿素氮 (BUN) 、肌酐 (Cre)] 及凝血功能的影响 [凝血酶时间 (TT),凝血酶原时间 (PT) 、活化部分凝血活酶时间 (APTT) 、纤维蛋白原 (FIB)] 进行检测.手术时间、术后情况术后 48 小时内 (时间的气管导管拔管,呼吸抑制/功能不全、变态反应、恶心呕吐、皮肤瘙痒,感觉异常,病理类型、术后住院时间记录.结果: 两组患者的年龄、性别比例、体重指数 (body mass index,BMI),美国麻醉医师协会 (ASA) 分级比例、手术持续时间,病理类型、术后住院时间、HR、MAP、QT间期无统计学意义 (均P>0.05).组比较无显著差异,血清组胺,丙氨酸氨基转移酶 (ALT) 、天冬氨酸氨基转移酶 (AST) 、血尿素氮 (BUN、Cre、凝血酶时间 (TT) 、凝血酶原时间 (PT) 、活化部分凝血活酶时间 (APTT) 和纤维蛋白原 (FIB) 给药前和给药后神经肌肉阻滞拮抗剂 (新斯的明或Sugammadex) 同组患者,差异有统计学意义 (P均> 0.05),也比较差异无统计学意义; C组和S组在相同的时间点差异均有统计学意义 (均P>0.05).平均时间的气管导管拔管S组 [(3.7 ± 1.3 分钟) 明显短于C组 [(14.5 ± 4.4) 分,差异有统计学意义 (t = 2.266,P<0.05).没有患者过敏,皮肤瘙痒,感觉异常研究组及对照组.两组患者的术后恶心和呕吐两组.5 例患者呼吸抑制C组和d组呼吸抑制患者S组,差异有统计学意义,两组间差异有统计学意义 (χ(2)= 5.263,P<0.05)。结论: Sugammadex可有效拮抗神经肌肉阻滞罗库溴铵患者肺癌根治术胸腔镜下,能缩短气管导管拔管后手术. : 目的: 探讨舒更葡糖钠用于胸腔镜肺癌根治术患者拮抗肌松药作用的有效性和安全性。方法: 本研究为前瞻性研究。选取 2019 年 3 至 9 月在郑州大学附属肿瘤医院拟行胸腔镜肺癌根治术患者 100 译,随机数字表法分为对照组(C组)、舒更葡糖钠组(S组)。两组患者均进行静脉靶控输注丙泊酚和瑞芬太尼、静脉推注罗库溴铵进行麻醉诱导和维持,脑电双频指数(BIS)监测麻醉深度,肌松监测仪(TOF)检测肌松,双腔导管气管内插管,单肺机械通气,术后患者自控镇痛(PCA)。c组患者在关闭胸腔后且有自主呼吸时静脉推注新斯的明 (2 mg)联合阿托品(0.5 ~ 1.0 mg)逆转肌松药作用;S组在关闭胸腔后TOF计数≥ 2 时(无论有无自主呼吸)静脉推注舒更葡糖钠(2 mg/kg);两组患者均参照拔管指征拔除气管导管。检测麻醉诱导前即刻(T(0))、气管插管前即刻(T(1) 条) 、关闭胸腔后即刻(T(2) 条) 、术后 1 h(T(3))、术后 6 h(T(4))、术后 24 h(T(5))、术后 48 h(T(6) 患者平均动脉压,心率,V3 导联心电图的QT间期,血清谷丙转氨酶 (丙氨酸氨基转移酶(ALT),谷草转氨酶氨基转移酶(AST),肾功能[血尿素氮(BUN)、血肌酐(Cre)]和凝血功能[血浆凝血酶时间(TT)、血浆凝血酶原时间(PT)、活化部分凝血活酶时间 (活化部分凝血活酶时间(APTT)、纤维蛋白原 (纤维蛋白原(FIB)],并记录患者的手术时间、气管导管拔除时间、术后 48 h内呼吸抑制、呼吸功能障碍、过敏、恶心呕吐、皮肤瘙痒、感觉异常的发生率,以及术后病理分型、术后住院天数等情况。结果: 两组患者年龄、性别、体质指数(BMI)、美国麻醉医师协会(ASA)分级、手术时间、术后病理分型、术后住院天数差异均无统计学意义(均P>0.05);两组患者心率、血压和QT间期差异均无统计学意义(均P>0.05);两组患者在应用肌松拮抗剂前后血清组胺、肝功能指标(ALT和AST)、肾功能指标(BUN和Cre)差异均无统计学意义(均P>0.05),相同时间点两组间血清组胺、肝功能指标、肾功能指标差异均无统计学意义(均P>0.05);两组患者在应用肌松拮抗剂前后出/凝血功能指标(TT、PT、APTT和FIB)差异均无统计学意义(均P>0.05),相同时间点两组间出/凝血功能指标差异均无统计学意义(均P>0.05);S组患者术后气管导管拔管时间为(3.7 ± 1.3) 分,短于C组患者的(14.5 ± 4.4) 分,差异有统计学意义,差异有统计学意义(t = 2.266,P<0.05);两组术后 48 h内均无呼吸功能障碍、过敏、皮肤瘙痒和感觉异常患者,术后恶心呕吐发生率两组差异无统计学意义,差异有统计学意义(P>0.05);术后 48 h内C组呼吸抑制患者 5 译,S组无呼吸抑制患者,差异有统计学意义(χ(2)= 5.263,P<0.05)。结论: 肺癌根治术患者术毕应用舒更葡糖钠拮抗罗库溴铵的肌松作用是有效的,可以缩短术后气管导管拔管时间。.

阅读人数:2人
下载该文献
小狗阅读

帮助医生、学生、科研工作者解决SCI文献找不到、看不懂、阅读效率低的问题。提供领域精准的SCI文献,通过多角度解析提高文献阅读效率,从而使用户获得有价值研究思路。

相关文献
影响因子:1.80
发表时间:2020-01-01
DOI:10.1016/j.athoracsur.2019.04.100
作者列表:["Mammana M","Zuin A","Serra E","Bellini A","Rea F"]

METHODS::Pulmonary artery sling is a rare congenital anomaly of the origin and course of the left pulmonary artery. Patients with this condition typically present with respiratory failure in young infancy, and asymptomatic cases are uncommon. We describe the case of an adult patient with a lung adenocarcinoma of the right upper lobe, extending into the hilum and superior mediastinum, and with a previously unknown pulmonary artery sling anomaly. The local invasiveness of the tumor and the peculiar vascular anatomy contributed to a unique surgical scenario, wherein multiple reconstructive procedures were required.

关键词: 暂无
翻译标题与摘要 下载文献
影响因子:6.93
发表时间:2020-01-15
DOI:10.1002/ijc.32532
作者列表:["Hata A","Nakajima T","Matsusaka K","Fukuyo M","Morimoto J","Yamamoto T","Sakairi Y","Rahmutulla B","Ota S","Wada H","Suzuki H","Matsubara H","Yoshino I","Kaneda A"]

METHODS::Patients with idiopathic pulmonary fibrosis (IPF) have higher risk of developing lung cancer, for example, squamous cell carcinoma (SCC), and show poor prognosis, while the molecular basis has not been fully investigated. Here we conducted DNA methylome analysis of lung SCC using 20 SCC samples with/without IPF, and noncancerous lung tissue samples from smokers/nonsmokers, using Infinium HumanMethylation 450K array. SCC was clustered into low- and high-methylation epigenotypes by hierarchical clustering analysis. Genes hypermethylated in SCC significantly included genes targeted by polycomb repressive complex in embryonic stem cells, and genes associated with Gene Ontology terms, for example, "transcription" and "cell adhesion," while genes hypermethylated specifically in high-methylation subgroup significantly included genes associated with "negative regulation of growth." Low-methylation subgroup significantly correlated with IPF (78%, vs. 17% in high-methylation subgroup, p = 0.04), and the correlation was validated by additional Infinium analysis of SCC samples (n = 44 in total), and data from The Cancer Genome Atlas (n = 390). The correlation between low-methylation subgroup and IPF was further validated by quantitative methylation analysis of marker genes commonly hypermethylated in SCC (HOXA2, HOXA9 and PCDHGB6), and markers specifically hypermethylated in high-methylation subgroup (DLEC1, CFTR, MT1M, CRIP3 and ALDH7A1) in 77 SCC cases using pyrosequencing (p = 0.003). Furthermore, low-methylation epigenotype significantly correlated with poorer prognosis among all SCC patients, or among patients without IPF. Multivariate analysis showed that low-methylation epigenotype is an independent predictor of poor prognosis. These may suggest that lung SCC could be stratified into molecular subtypes with distinct prognosis, and low-methylation lung SCC that significantly correlates with IPF shows unfavorable outcome.

翻译标题与摘要 下载文献
影响因子:6.93
发表时间:2020-01-01
DOI:10.1002/ijc.32530
作者列表:["Zhang L","Yang Y","Chai L","Bu H","Yang Y","Huang H","Ran J","Zhu Y","Li L","Chen F","Li W"]

METHODS::The role of Fyn-related kinase (FRK) in malignant tumors remains controversial. Our study investigated the function of FRK in lung cancer. Immunohistochemistry staining and generating a knockout of FRK by CRISPR/Cas9 in H1299 (FRK-KO-H1299) cells were strategies used to explore the role of FRK. Immunohistochemistry staining indicated that FRK expression was elevated in 223 lung cancer tissues compared to 26 distant normal lung tissues. FRK contributed to poor survival status in lung cancer patients and acted as a predictor for poor prognosis of lung cancer. Knockout of FRK by CRISPR/Cas9 markedly inhibited proliferation, invasion, colony formation and epithelial-mesenchymal transition (EMT) process in the lung cancer cell line H1299. Further exploration indicated that FRK-KO damaged the stemness phenotype of H1299 by inhibiting CD44 and CD133 expression. Seahorse detection and a U-13 C flux assay revealed that FRK-KO induced metabolism reprogramming by inhibiting the Warburg effect and changing the energy type in H1299 cells. Epidermal growth factor stimulation recovered the expression of FRK and biological functions, metabolic reprogramming and stemness phenotype of H1299 cells. FRK plays an oncogenic role in lung cancer cells via a novel regulation mechanism of enhancing the stemness of H1299 cells by inducing metabolism reprogramming, which finally promotes EMT and metastasis. Our study also indicates that FRK could be used as a potential therapeutic target for drug development.

翻译标题与摘要 下载文献
肺肿瘤方向

肺肿瘤,又叫支气管肺癌,是常见的恶性肿瘤之一。肺肿瘤的治疗为包括手术、中药、放疗、化疗及免疫等多学科的综合治疗。

复制标题
发送后即可在该邮箱或我的下载查看该文献
发送
该文献默认存储到我的下载

科研福利

报名咨询

建议反馈
问题标题:
联系方式:
电子邮件:
您的需求: